Blood–brain barrier structure and function and the challenges for CNS drug delivery
The DOI matches its Crossref record; 136 of the 136 references it cites were found in a registry or an index.
Abstract
The neurons of the central nervous system (CNS) require precise control of their bathing microenvironment for optimal function, and an important element in this control is the blood–brain barrier (BBB). The BBB is formed by the endothelial cells lining the brain microvessels, under the inductive influence of neighbouring cell types within the ‘neurovascular unit’ (NVU) including astrocytes and pericytes. The endothelium forms the major interface between the blood and the CNS, and by a combination of low passive permeability and presence of specific transport systems, enzymes and receptors regulates molecular and cellular traffic across the barrier layer. A number of methods and models are available for examining BBB permeation in vivo and in vitro, and can give valuable information on the mechanisms by which therapeutic agents and constructs permeate, ways to optimize permeation, and implications for drug discovery, delivery and toxicity. For treating lysosomal storage diseases (LSDs), models can be included that mimic aspects of the disease, including genetically‐modified animals, and in vitro models can be used to examine the effects of cells of the NVU on the BBB under pathological conditions. For testing CNS drug delivery, several in vitro models now provide reliable prediction of penetration of drugs including large molecules and artificial constructs with promising potential in treating LSDs. For many of these diseases it is still not clear how best to deliver appropriate drugs to the CNS, and a concerted approach using a variety of models and methods can give critical insights and indicate practical solutions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1982) · Trends in Neurosciences · doi:10.1016/0166-2236(82)90076-5 · Cited by 9,089
Astrocyte-endothelial interactions at the blood-brain barrier
Abbott, N. J., Rönnbäck, L., & Hansson, E. (2006) · Nature Reviews Neuroscience · doi:10.1038/nrn1824 · Cited by 5,595
Self-citationStructure and function of the blood–brain barrier
Abbott, N. J., Patabendige, A. A. K., Dolman, D. E. M., Yusof, S. R., & Begley, D. J. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.07.030 · Cited by 5,185
Self-citationPericytes regulate the blood–brain barrier
Armulik, A., Genové, G., Mäe, M., Nisancioglu, M. H., Wallgard, E., Niaudet, C., He, L., Norlin, J., Lindblom, P., Strittmatter, K., et al. (2010) · Nature · doi:10.1038/nature09522 · Cited by 2,843
Pericytes: Developmental, Physiological, and Pathological Perspectives, Problems, and Promises
Armulik, A., Genové, G., & Betsholtz, C. (2011) · Developmental Cell · doi:10.1016/j.devcel.2011.07.001 · Cited by 2,653
Pericytes are required for blood–brain barrier integrity during embryogenesis
Daneman, R., Zhou, L., Kebede, A. A., & Barres, B. A. (2010) · Nature · doi:10.1038/nature09513 · Cited by 2,128
The role of inflammation in epilepsy
Vezzani, A., French, J., Bartfai, T., & Baram, T. Z. (2011) · Nature Reviews Neurology · doi:10.1038/nrneurol.2010.178 · Cited by 1,876
Pathways of clathrin-independent endocytosis
Mayor, S., & Pagano, R. E. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2216 · Cited by 1,556
Medicinal chemical properties of successful central nervous system drugs
Pajouhesh, H., & Lenz, G. R. (2005) · NeuroRX · doi:10.1602/neurorx.2.4.541 · Cited by 1,535
Bell, R. D., Winkler, E. A., Sagare, A. P., Singh, I., LaRue, B., Deane, R., & Zlokovic, B. V. (2010) · Neuron · doi:10.1016/j.neuron.2010.09.043 · Cited by 1,448
Glial regulation of the cerebral microvasculature
Iadecola, C., & Nedergaard, M. (2007) · Nature Neuroscience · doi:10.1038/nn2003 · Cited by 1,153 · cited 1×
“Recent studies show that a complex local grouping of non-neuronal cells supports groups of neurons within a modular neurovascular unit, initially described in relation to regulation of local cerebral blood flow at the level of cerebral arterioles, and involving astrocytes and smooth muscle cells (Iadecola and Nedergaa…”
BackgroundThe anatomical and cellular basis of immune surveillance in the central nervous system
Ransohoff, R. M., & Engelhardt, B. (2012) · Nature Reviews Immunology · doi:10.1038/nri3265 · Cited by 972
Generation of a Set of Simple, Interpretable ADMET Rules of Thumb
Gleeson, M. P. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm701122q · Cited by 969
Central nervous system pericytes in health and disease
Winkler, E. A., Bell, R. D., & Zlokovic, B. V. (2011) · Nature Neuroscience · doi:10.1038/nn.2946 · Cited by 962
Derivation of blood-brain barrier endothelial cells from human pluripotent stem cells
Lippmann, E. S., Azarin, S. M., Kay, J. E., Nessler, R. A., Wilson, H. K., Al-Ahmad, A., Palecek, S. P., & Shusta, E. V. (2012) · Nature Biotechnology · doi:10.1038/nbt.2247 · Cited by 800
Evidence for bulk flow of brain interstitial fluid: significance for physiology and pathology
Abbott, N. J. (2004) · Neurochemistry International · doi:10.1016/j.neuint.2003.11.006 · Cited by 786
Self-citationNeurovascular mechanisms of Alzheimer's neurodegeneration
Zlokovic, B. V. (2005) · Trends in Neurosciences · doi:10.1016/j.tins.2005.02.001 · Cited by 770
Wnt/β-catenin signaling is required for CNS, but not non-CNS, angiogenesis
Daneman, R., Agalliu, D., Zhou, L., Kuhnert, F., Kuo, C. J., & Barres, B. A. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0805165106 · Cited by 753
A new blood–brain barrier model using primary rat brain endothelial cells, pericytes and astrocytes
Nakagawa, S., Deli, M. A., Kawaguchi, H., Shimizudani, T., Shimono, T., Kittel, Á., Tanaka, K., & Niwa, M. (2009) · Neurochemistry International · doi:10.1016/j.neuint.2008.12.002 · Cited by 728
Lockman, P. R., Mittapalli, R. K., Taskar, K. S., Rudraraju, V., Gril, B., Bohn, K. A., Adkins, C. E., Roberts, A., Thorsheim, H. R., Gaasch, J. A., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-1564 · Cited by 693
The Use of Inhibitors to Study Endocytic Pathways of Gene Carriers: Optimization and Pitfalls
Vercauteren, D., Vandenbroucke, R. E., Jones, A. T., Rejman, J., Demeester, J., De Smedt, S. C., Sanders, N. N., & Braeckmans, K. (2010) · Molecular Therapy · doi:10.1038/mt.2009.281 · Cited by 689
Capture, crawl, cross: the T cell code to breach the blood–brain barriers
Engelhardt, B., & Ransohoff, R. M. (2012) · Trends in Immunology · doi:10.1016/j.it.2012.07.004 · Cited by 686
CNS Delivery Via Adsorptive Transcytosis
Hervé, F., Ghinea, N., & Scherrmann, J.-M. (2008) · The AAPS Journal · doi:10.1208/s12248-008-9055-2 · Cited by 676
Heterogeneity of CNS myeloid cells and their roles in neurodegeneration
Prinz, M., Priller, J., Sisodia, S. S., & Ransohoff, R. M. (2011) · Nature Neuroscience · doi:10.1038/nn.2923 · Cited by 674
Permeability Studies on In Vitro Blood–Brain Barrier Models: Physiology, Pathology, and Pharmacology
Deli, M. A., Ábrahám, C. S., Kataoka, Y., & Niwa, M. (2005) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-004-1377-8 · Cited by 643
Modelling of the blood–brain barrier in drug discovery and development
Cecchelli, R., Berezowski, V., Lundquist, S., Culot, M., Renftel, M., Dehouck, M.-P., & Fenart, L. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2368 · Cited by 618
Engaging neuroscience to advance translational research in brain barrier biology
Neuwelt, E. A., Bauer, B., Fahlke, C., Fricker, G., Iadecola, C., Janigro, D., Leybaert, L., Molnár, Z., O'Donnell, M. E., Povlishock, J. T., et al. (2011) · Nature Reviews Neuroscience · doi:10.1038/nrn2995 · Cited by 579
Sengillo, J. D., Winkler, E. A., Walker, C. T., Sullivan, J. S., Johnson, M., & Zlokovic, B. V. (2013) · Brain Pathology · doi:10.1111/bpa.12004 · Cited by 553
Blood–Brain Barrier Transport of Therapeutics via Receptor-Mediation
Jones, A. R., & Shusta, E. V. (2007) · Pharmaceutical Research · doi:10.1007/s11095-007-9379-0 · Cited by 549 · cited 1×
“peptides and proteins) gain access are less clear (Jones and Shusta 2007).”
BackgroundOn The Rate and Extent of Drug Delivery to the Brain
Hammarlund-Udenaes, M., Fridén, M., Syvänen, S., & Gupta, A. (2008) · Pharmaceutical Research · doi:10.1007/s11095-007-9502-2 · Cited by 513
Hamilton, N. B. (2010) · Frontiers in Neuroenergetics · doi:10.3389/fnene.2010.00005 · Cited by 513
Barrier Mechanisms in the Developing Brain
Saunders, N. R., Liddelow, S. A., & Dziegielewska, K. M. (2012) · Frontiers in Pharmacology · doi:10.3389/fphar.2012.00046 · Cited by 502
Ohtsuki, S., & Terasaki, T. (2007) · Pharmaceutical Research · doi:10.1007/s11095-007-9374-5 · Cited by 454
Absorption and Drug Development: Solubility, Permeability, and Charge State
Avdeef, A. (2012) · Wiley eBooks · doi:10.1002/9781118286067 · Cited by 446
Structural and functional aspects of the blood-brain barrier
Begley, D. J., & Brightman, M. W. (2003) · Peptide Transport and Delivery into the Central Nervous System · doi:10.1007/978-3-0348-8049-7_2 · Cited by 445
Redzic, Z. (2011) · Fluids and Barriers of the CNS · doi:10.1186/2045-8118-8-3 · Cited by 418
Insulin-like growth factors cross the blood-brain barrier
Reinhardt, R., & Bondy, C. A. (1994) · Endocrinology · doi:10.1210/en.135.5.1753 · Cited by 391
Receptor-mediated Transcytosis of Lactoferrin through the Blood-Brain Barrier
Fillebeen, C., Descamps, L., Dehouck, M.-P., Fenart, L., Benaı̈ssa, M., Spik, G., Cecchelli, R., & Pierce, A. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.11.7011 · Cited by 385
In vitro model for evaluating drug transport across the blood–brain barrier
Cecchelli, R., Dehouck, B., Descamps, L., Fenart, L., Buée-Scherrer, V, Duhem, C., Lundquist, S., Rentfel, M., Torpier, G., & Dehouck, M. P. (1999) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(98)00083-0 · Cited by 383
Shawahna, R., Uchida, Y., Declèves, X., Ohtsuki, S., Yousif, S., Dauchy, S., Jacob, A., Chassoux, F., Daumas-Duport, C., Couraud, P.-O., et al. (2011) · Molecular Pharmaceutics · doi:10.1021/mp200129p · Cited by 372
Common and Uncommon Pathogenic Cascades in Lysosomal Storage Diseases
Vitner, E. B., Platt, F. M., & Futerman, A. H. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.r110.134452 · Cited by 369
Overview and introduction: The blood–brain barrier in health and disease
Abbott, N. J., & Friedman, A. (2012) · Epilepsia · doi:10.1111/j.1528-1167.2012.03696.x · Cited by 362
Self-citationRegulation of P-glycoprotein and other ABC drug transporters at the blood–brain barrier
Miller, D. S. (2010) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2010.03.003 · Cited by 361
Blood–spinal cord barrier breakdown and pericyte reductions in amyotrophic lateral sclerosis
Winkler, E. A., Sengillo, J. D., Sullivan, J. S., Henkel, J. S., Appel, S. H., & Zlokovic, B. V. (2013) · Acta Neuropathologica · doi:10.1007/s00401-012-1039-8 · Cited by 354
Pathophysiology of the Neurovascular Unit: Disease Cause or Consequence?
Stanimirovic, D. B., & Friedman, A. (2012) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2012.25 · Cited by 346
Dauchy, S., Dutheil, F., Weaver, R. J., Chassoux, F., Daumas‐Duport, C., Couraud, P., Scherrmann, J., De Waziers, I., & Declèves, X. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05720.x · Cited by 332
Immunologic Privilege in the Central Nervous System and the Blood–Brain Barrier
Muldoon, L. L., Alvarez, J. I., Begley, D. J., Boado, R. J., del Zoppo, G. J., Doolittle, N. D., Engelhardt, B., Hallenbeck, J. M., Lonser, R. R., Ohlfest, J. R., et al. (2013) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2012.153 · Cited by 321
Mechanisms of Disease: The Blood-Brain Barrier
Neuwelt, E. A. (2004) · Neurosurgery · doi:10.1227/01.neu.0000097715.11966.8e · Cited by 314
In vitro models of the blood-brain barrier
Wilhelm, I., Fazakas, C., & Krizbai, I. (2011) · Acta Neurobiologiae Experimentalis · doi:10.55782/ane-2011-1828 · Cited by 298
In Vitro Blood–Brain Barrier Models: Current and Perspective Technologies
Naik, P., & Cucullo, L. (2012) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.23022 · Cited by 288
Structure and Function of the Human Breast Cancer Resistance Protein (BCRP/ABCG2)
Ni, Z., Bikadi, Z., F. Rosenberg, M., & Mao, Q. (2010) · Current Drug Metabolism · doi:10.2174/138920010792927325 · Cited by 277
Clarifying lysosomal storage diseases
Schultz, M. L., Tecedor, L., Chang, M., & Davidson, B. L. (2011) · Trends in Neurosciences · doi:10.1016/j.tins.2011.05.006 · Cited by 245
Targeted delivery of proteins across the blood–brain barrier
Spencer, B. J., & Verma, I. M. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0702170104 · Cited by 239
In Vitro Models of the Blood-Brain Barrier
Neuhaus, W. (2020) · Handbook of Experimental Pharmacology · doi:10.1007/164_2020_370 · Cited by 236
Blood–Spinal Cord Barrier Pericyte Reductions Contribute to Increased Capillary Permeability
Winkler, E. A., Sengillo, J. D., Bell, R. D., Wang, J., & Zlokovic, B. V. (2012) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2012.113 · Cited by 226
Will the original glucose transporter isoform please stand up!
Carruthers, A., DeZutter, J., Ganguly, A., & Devaskar, S. U. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00496.2009 · Cited by 201
Fu, H., DiRosario, J., Killedar, S., Zaraspe, K., & McCarty, D. M. (2011) · Molecular Therapy · doi:10.1038/mt.2011.34 · Cited by 197
Neurodegeneration and the neurovascular unit
Zlokovic, B. V. (2010) · Nature Medicine · doi:10.1038/nm1210-1370 · Cited by 189
Reichel, A. (2009) · Chemistry & Biodiversity · doi:10.1002/cbdv.200900103 · Cited by 185
Franke, H., Galla, H.-J., & Beuckmann, C. T. (1999) · Brain Research · doi:10.1016/s0006-8993(98)01282-7 · Cited by 183
Abbott, N. J. (2004) · Drug Discovery Today: Technologies · doi:10.1016/j.ddtec.2004.11.014 · Cited by 181
Self-citationVisigalli, I., Delai, S., Politi, L. S., Di Domenico, C., Cerri, F., Mrak, E., D'Isa, R., Ungaro, D., Stok, M., Sanvito, F., et al. (2010) · Blood · doi:10.1182/blood-2010-04-278234 · Cited by 174
Lundquist, S., Renftel, M., Brillault, J., Fenart, L., Cecchelli, R., & Dehouck, M.-P. (2002) · Pharmaceutical Research · doi:10.1023/a:1016462205267 · Cited by 173
Vogler, C., Levy, B., Grubb, J. H., Galvin, N., Tan, Y., Kakkis, E., Pavloff, N., & Sly, W. S. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506892102 · Cited by 172
Receptor-mediated transcytosis of transferrin through blood-brain barrier endothelial cells
Descamps, L., Dehouck, M. P., Torpier, G., & Cecchelli, R. (1996) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1996.270.4.h1149 · Cited by 166
Urayama, A., Grubb, J. H., Sly, W. S., & Banks, W. A. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0405042101 · Cited by 165
Dickson, P., McEntee, M., Vogler, C., Le, S., Levy, B., Peinovich, M., Hanson, S., Passage, M., & Kakkis, E. (2007) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2006.12.012 · Cited by 163
Platt, F. M., & Jeyakumar, M. (2008) · Acta Paediatrica · doi:10.1111/j.1651-2227.2008.00656.x · Cited by 151
Vitner, E. B., Farfel-Becker, T., Eilam, R., Biton, I., & Futerman, A. H. (2012) · Brain · doi:10.1093/brain/aws095 · Cited by 149
Matzner, U., Herbst, E., Hedayati, K. K., Lüllmann-Rauch, R., Wessig, C., Schröder, S., Eistrup, C., Möller, C., Fogh, J., & Gieselmann, V. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi126 · Cited by 149
Lysosomal Storage Diseases and the Blood-Brain Barrier
Begley, D., Pontikis, C., & Scarpa, M. (2008) · Current Pharmaceutical Design · doi:10.2174/138161208784705504 · Cited by 145
Pathophysiology of neuropathic lysosomal storage disorders
Bellettato, C. M., & Scarpa, M. (2010) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-010-9075-9 · Cited by 141
Malinowska, M., Wilkinson, F. L., Langford-Smith, K. J., Langford-Smith, A., Brown, J. R., Crawford, B. E., Vanier, M. T., Grynkiewicz, G., Wynn, R. F., Wraith, J. E., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0014192 · Cited by 139
Patabendige, A., Skinner, R. A., & Abbott, N. J. (2013) · Brain Research · doi:10.1016/j.brainres.2012.06.057 · Cited by 136
Self-citationThanabalasundaram, G., Schneidewind, J., Pieper, C., & Galla, H. (2011) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2011.05.002 · Cited by 134
An Overview of In Vitro Techniques for Blood-Brain Barrier Studies
Reichel, A., Begley, D. J., & Abbott, N. J. (2003) · Blood-Brain Barrier, · doi:10.1385/1-59259-419-0:307 · Cited by 134
Self-citationCalias, P., Papisov, M., Pan, J., Savioli, N., Belov, V., Huang, Y., Lotterhand, J., Alessandrini, M., Liu, N., Fischman, A. J., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030341 · Cited by 133
Predicting Blood-Brain Barrier Permeability of Drugs: Evaluation of Different In Vitro Assays
Lohmann, C., Hüwel, S., & Galla, H. (2002) · Journal of drug targeting · doi:10.1080/10611860290031903 · Cited by 132
Candela, P., Gosselet, F., Saint-Pol, J., Sevin, E., Boucau, M.-C., Boulanger, E., Cecchelli, R., & Fenart, L. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-100462 · Cited by 128
Endothelial transcytosis in health and disease
Simionescu, M., Popov, D., & Sima, A. V. (2008) · Cell and Tissue Research · doi:10.1007/s00441-008-0688-3 · Cited by 128
Uptake and permeability studies of BBB-targeting immunoliposomes using the hCMEC/D3 cell line.
Markoutsa, E., Pampalakis, G., Niarakis, A., Romero, I. A., Weksler, B., Couraud, P.-O., & Antimisiaris, S. G. (2011) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2010.11.015 · Cited by 122
Theranostic liposomes loaded with quantum dots and apomorphine for brain targeting and bioimaging
Fang, J.-Y., Wen, C.-J., Zhang, Al-Suwayeh, & Yen, T.-C. (2012) · International Journal of Nanomedicine · doi:10.2147/ijn.s29369 · Cited by 122
Farfel-Becker, T., Vitner, E. B., Pressey, S. N. R., Eilam, R., Cooper, J. D., & Futerman, A. H. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr019 · Cited by 119
Candela, P., Gosselet, F., Miller, F., Buee-Scherrer, V., Torpier, G., Cecchelli, R., & Fenart, L. (2008) · Endothelium · doi:10.1080/10623320802487759 · Cited by 117
Bikádi, Z., Hazai, I., Malik, D., Jemnitz, K., Veres, Z., Hári, P., Ni, Z., Loo, T. W., Clarke, D. M., Hazai, E., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025815 · Cited by 117
Grubb, J. H., Vogler, C. A., Levy, B. K., Galvin, N. J., Tan, Y., & Sly, W. S. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0712147105 · Cited by 117
A Review of Blood–Brain Barrier Transport Techniques
Smith, Q. R. (2003) · Blood-Brain Barrier, · doi:10.1385/1-59259-419-0:193 · Cited by 113
New strategies for the treatment of lysosomal storage diseases (Review)
PARENTI, G., PIGNATA, C., VAJRO, P., & SALERNO, M. (2013) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2012.1187 · Cited by 110
Is there a clinical future for polymeric nanoparticles as brain-targeting drug delivery agents?
Costantino, L., & Boraschi, D. (2012) · Drug Discovery Today · doi:10.1016/j.drudis.2011.10.028 · Cited by 106
Modelling the Neurovascular Unit and the Blood-Brain Barrier with the Unique Function of Pericytes
Vandenhaute, E., Dehouck, L., Boucau, M.-C., Sevin, E., Uzbekov, R., Tardivel, M., Gosselet, F., Fenart, L., Cecchelli, R., & Dehouck, M.-P. (2011) · Current Neurovascular Research · doi:10.2174/156720211798121016 · Cited by 106
Arfı, A., Richard, M., Gandolphe, C., Bonnefont‐Rousselot, D., Thérond, P., & Scherman, D. (2011) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2011.01.015 · Cited by 101
Tosi, G., Fano, R. A., Bondioli, L., Badiali, L., Benassi, R., Rivasi, F., Ruozi, B., Forni, F., & Vandelli, M. A. (2011) · Nanomedicine · doi:10.2217/nnm.11.11 · Cited by 99
Comparative Physiology of the Blood-Brain Barrier
Abbott, N. J. (1992) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-76894-1_15 · Cited by 98
Self-citationTsinman, O., Tsinman, K., Sun, N., & Avdeef, A. (2011) · Pharmaceutical Research · doi:10.1007/s11095-010-0280-x · Cited by 97
Ghosh, C., Puvenna, V., Gonzalez-Martinez, J., Janigro, D., & Marchi, N. (2011) · Current Drug Metabolism · doi:10.2174/138920011798357051 · Cited by 95
Transport of interleukin‐1 across cerebromicrovascular endothelial cells
Skinner, R., Gibson, R., Rothwell, N., Pinteaux, E., & Penny, J. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2008.00129.x · Cited by 93
Tanycytes and pituicytes: Morphological and functional aspects of neuroglial interaction
Wittkowski, W. (1998) · Microscopy Research and Technique · doi:10.1002/(sici)1097-0029(19980401)41:1<29::aid-jemt4>3.0.co;2-p · Cited by 93
Circumventricular organs: Receptive and homeostatic functions and clinical implications
Benarroch, E. E. (2011) · Neurology · doi:10.1212/wnl.0b013e31822f04a0 · Cited by 93
Stamatovic, S. M., Sladojević, N., Keep, R. F., & Andjelkovic, A. V. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.06678-11 · Cited by 93
Absence of albumin receptor on brain capillaries in vivo or in vitro
Pardridge, W. M., Eisenberg, J., & Cefalu, W. T. (1985) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1985.249.3.e264 · Cited by 82
Cabrera-Salazar, M. A., DeRiso, M., Bercury, S. D., Li, L., Lydon, J. T., Weber, W., Pande, N., Cromwell, M. A., Copeland, D., Leonard, J., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0043310 · Cited by 80
New Strategies for Enzyme Replacement Therapy for Lysosomal Storage Diseases
Grubb, J. H., Vogler, C., & Sly, W. S. (2010) · Rejuvenation Research · doi:10.1089/rej.2009.0920 · Cited by 79
Dutheil, F., Jacob, A., Dauchy, S., Beaune, P. H., Scherrmann, J., Declèves, X., & Loriot, M. (2010) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2010.510832 · Cited by 79
Liddelow, S. A., Temple, S., Møllgård, K., Gehwolf, R., Wagner, A., Bauer, H., Bauer, H.-C., Phoenix, T. N., Dziegielewska, K. M., & Saunders, N. R. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033554 · Cited by 76
Dagenais, C., Avdeef, A., Tsinman, O., Dudley, A., & Beliveau, R. (2009) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2009.06.009 · Cited by 75
Markoutsa, E., Παπαδιά, Κ., Clemente, C., Flores, O., & Antimisiaris, S. G. (2012) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2012.02.006 · Cited by 67
In Vitro Modeling of the Blood-Brain Barrier: Simplicity Versus Complexity
Ogunshola, O. O. (2011) · Current Pharmaceutical Design · doi:10.2174/138161211797440159 · Cited by 67
Matzner, U., Lüllmann-Rauch, R., Stroobants, S., Andersson, C., Weigelt, C., Eistrup, C., Fogh, J., D'Hooge, R., & Gieselmann, V. (2009) · Molecular Therapy · doi:10.1038/mt.2008.305 · Cited by 66
Prediction of blood–brain barrier penetration: are we missing the point?
Martin, I. J. (2004) · Drug Discovery Today · doi:10.1016/s1359-6446(03)02961-1 · Cited by 64
Stroobants, S., Gerlach, D., Matthes, F., Hartmann, D., Fogh, J. M., Gieselmann, V., D’Hooge, R., & Matzner, U. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr175 · Cited by 64
Saha, A., Sarkar, C., Singh, S. P., Zhang, Z., Munasinghe, J., Peng, S., Chandra, G., Kong, E., & Mukherjee, A. B. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds038 · Cited by 63
García, M. D. L. Á., Carrasco, M. A., Godoy, A., Reinicke, K., Montecinos, V. P., Aguayo, L. G., Tapia, J. C., Vera, J. C., & Nualart, F. (2001) · Journal of Cellular Biochemistry · doi:10.1002/1097-4644(20010315)80:4<491::aid-jcb1003>3.0.co;2-7 · Cited by 58
Avdeef, A. (2011) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2011.04.001 · Cited by 57
Dohgu, S., Ryerse, J. S., Robinson, S. M., & Banks, W. A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0039565 · Cited by 52
Ylikangas, H., Peura, L., Malmioja, K., Leppänen, J., Laine, K., Poso, A., Lahtela-Kakkonen, M. K., & Rautio, J. (2012) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2012.11.014 · Cited by 51
Therapeutic approaches for neuronopathic lysosomal storage disorders
Schiffmann, R. (2010) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-010-9047-0 · Cited by 50
Diphtheria Toxin Mutant CRM197-Mediated Transcytosis across Blood–Brain Barrier In Vitro
Wang, P., Xue, Y., Shang, X., & Liu, Y. (2010) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-010-9496-x · Cited by 49
Human ABC transporters ABCG2 (BCRP) and ABCG4
Koshiba, S., An, R., Saito, H., Wakabayashi, K., Tamura, A., & Ishikawa, T. (2008) · Xenobiotica · doi:10.1080/00498250801986944 · Cited by 47
Chen, Y. H., Claflin, K., Geoghegan, J. C., & Davidson, B. L. (2012) · Molecular Therapy · doi:10.1038/mt.2012.100 · Cited by 46
Killedar, S., DiRosario, J., DiCaprio, E. L., Popovich, P. G., McCarty, D. M., & Fu, H. (2010) · Journal of Neuroinflammation · doi:10.1186/1742-2094-7-39 · Cited by 46
I. Dickson, P., & H. Chen, A. (2011) · Current Pharmaceutical Biotechnology · doi:10.2174/138920111795542642 · Cited by 38
Slice Cultures as a Model to Study Neurovascular Coupling and Blood Brain Barrier In Vitro
Kovács, R., Papageorgiou, I., & Heinemann, U. (2011) · Cardiovascular Psychiatry and Neurology · doi:10.1155/2011/646958 · Cited by 34
Ni, Z., Bikádi, Z., Shuster, D. L., Zhao, C., Rosenberg, M. F., & Mao, Q. (2011) · Biochemistry · doi:10.1021/bi200573t · Cited by 33
Blood-brain barrier impairment in an animal model of MPS III b
Garbuzova-Davis, S., Louis, M. K., Haller, E. M., Derasari, H. M., Rawls, A. E., & Sanberg, P. R. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016601 · Cited by 32
Lessons learnt from animal models: pathophysiology of neuropathic lysosomal storage disorders
Hemsley, K. M., & Hopwood, J. J. (2010) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-010-9078-6 · Cited by 31
Derrick‐Roberts, A. L. K., Fletcher, J. M., Moore, L., & Byers, S. (2010) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2010.06.008 · Cited by 29
Guffon, N., Bin-Dorel, S., Decullier, É., Paillet, C., Guitton, J., & Fouilhoux, A. (2011) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2011.04.040 · Cited by 28
In Vitro Models of the Blood–Brain Barrier
Shah, K. K., Yang, L., & Abbruscato, T. J. (2011) · Methods in molecular biology · doi:10.1007/978-1-61779-452-0_29 · Cited by 27
Tomanin, R., Zanetti, A., Zaccariotto, E., D’Avanzo, F., Bellettato, C. M., & Scarpa, M. (2012) · Acta Paediatrica · doi:10.1111/j.1651-2227.2012.02674.x · Cited by 27
Liu, M., Hou, T., Feng, Z., & Li, Y. (2012) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2012.706079 · Cited by 27
Transport of Arylsulfatase A across the Blood-Brain Barrier in Vitro
Matthes, F., Wölte, P., Böckenhoff, A., Hüwel, S., Schulz, M., Hydén, P., Fogh, J. M., Gieselmann, V., Galla, H., & Matzner, U. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.189381 · Cited by 27
Jolly, R. D., Marshall, N. R., Perrott, M. R., Dittmer, K. E., Hemsley, K. M., & Beard, H. (2010) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2010.01158.x · Cited by 22
Therapies for Neurological Disease in the Mucopolysaccharidoses
Anson, D. S., McIntyre, C., & Byers, S. (2011) · Current Gene Therapy · doi:10.2174/156652311794940791 · Cited by 21
Haqqani, A. S., & Stanimirovic, D. B. (2011) · Cardiovascular Psychiatry and Neurology · doi:10.1155/2011/175364 · Cited by 16
Delivery of drugs to the brain via the blood brain barrier using colloidal carriers
Tucker, I. G., Yang, L., & Mujoo, H. (2012) · Journal of Microencapsulation · doi:10.3109/02652048.2012.658445 · Cited by 13
Ishikawa, T., Saito, H., Hirano, H., Inoue, Y., & Ikegami, Y. (2012) · Methods in molecular biology · doi:10.1007/978-1-61779-965-5_11 · Cited by 11
Cited by
The blood–brain barrier: Structure, regulation and drug delivery
Wu, D., Chen, Q., Chen, X., Han, F., Chen, Z., & Wang, Y. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01481-w · Cited by 1,906
The Microenvironmental Landscape of Brain Tumors
Quail, D. F., & Joyce, J. A. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.02.009 · Cited by 1,862
The blood–brain barrier and blood–tumour barrier in brain tumours and metastases
Arvanitis, C. D., Ferraro, G. B., & Jain, R. K. (2020) · Nature Reviews Cancer · doi:10.1038/s41568-019-0205-x · Cited by 1,792
Löscher, W., Potschka, H., Sisodiya, S. M., & Vezzani, A. (2020) · Pharmacological Reviews · doi:10.1124/pr.120.019539 · Cited by 903
A new look at cerebrospinal fluid circulation
Brinker, T., Stopa, E., Morrison, J., & Klinge, P. (2014) · Fluids and Barriers of the CNS · doi:10.1186/2045-8118-11-10 · Cited by 819
“Recent research has unveiled that the ‘barrier’ function of the BBB is in fact the result of highly regulated and complex cellular and molecular transport processes, which allow for the transport of water, solutes, larger molecules and even cells (reviewed by [108-110]).”
Background
Metadata
- Authors
- Abbott, N. J.
- Venue
- Journal of Inherited Metabolic Disease
- Publisher
- Wiley
- Published
- 2013-04-23
- Volume
- 36
- Issue
- 3
- Pages
- 437-449
- ISSN
- 0141-8955 (ISSN-L)
- 1573-2665
- OpenAlex
- W1965522214
- Cited by
- 909
- References
- 136
- FWCI
- 24.58
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.